International Journal of Infectious Diseases
Volume 12, Issue 4 , Pages 380-386 , July 2008

Epidemiology and outcomes of bacterial meningitis in Mexican children: 10-year experience (1993–2003)

Received 25 June 2007 ,Accepted 18 September 2007.

References 

  1. Parent du Châtelet I, Traore Y, Gessner BD, Antignac A, Naccro B, Njanpop-Lafourcade BM, et al. Bacterial meningitis in Burkina Faso: Surveillance using field-based polymerase chain-reaction testing. Clin Infect Dis. 2005;40:17–25
  2. Hui AC, Ng KC, Tong PY, Mok V, Chow KM, Wu A, et al. Bacterial meningitis in Hong Kong: 10-years’ experience. Clin Neurol Neurosurg. 2005;107:366–370
  3. Dawson KG, Emerson JC, Burns JL. Fifteen years of experience with bacterial meningitis. Pediatr Infect Dis J. 1999;18:816–822
  4. Mwangi I, Berkley J, Lowe B, Peshu N, Marsh K, Newton CR. Acute bacterial meningitis in children admitted to a rural Kenyan hospital: increasing antibiotic resistance and outcome. Pediatr Infect Dis J. 2002;21:1042–1048
  5. World Health Organization . Haemophilus influenzae type b (Hib) meningitis in the pre-vaccine era: a global review of incidence, age distributions, and case–fatality rates. Geneva, Switzerland: WHO; 2002;p. 1–39
  6. van de Beek D, de Gans J, Tunkel AR, Wijdicks FM. Community-acquired bacterial meningitis in adults. N Engl J Med. 2006;354:44–53
  7. Almeida-Gonzalez L, Franco-Paredes C, Fernando-Perez LF, Santos-Preciado JI. Meningococcal disease caused by Neisseria meningitidis: epidemiological, clinical, and preventive strategies. Salud Publ Mex. 2004;46:438–450
  8. Neuman HB, Wald ER. Bacterial meningitis in childhood at the Children's Hospital of Pittsburgh: 1988–1998. Clin Pediatr (Phila). 2001;40:595–600
  9. Robbins JB, Schneerson R, Gotschlich EC. Surveillance for bacterial meningitis by means of polymerase chain reaction. Clin Infect Dis. 2005;40:26–27
  10. Quagliarello VJ, Scheld WM. Treatment of bacterial meningitis. N Engl J Med. 2001;336:708–716
  11. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267–1284
  12. Husain EH, Al-Shawaf F, Bahbahani E, El-Nabi MH, Al-Fotooh KA, Shafiq MH, et al. Epidemiology of childhood meningitis in Kuwait. Med Sci Monit. 2007;13:CR220–CR223
  13. Levine OS, O’Brien KL, Knoll M, Adegbola RA, Black S, Cherian T, et al. Pneumococcal vaccination in developing countries. Lancet. 2006;367:1880–1882
  14. Husain EH, Chawla R, Dobson S, Dele Davies H. Epidemiology and outcome of bacterial meningitis in Canadian children: 1998–1999. Clin Invest Med. 2006;29:131–135
  15. Clemens J, Jodar L. Hib vaccines for all the world's children?. Lancet. 2005;366:101–102
  16. World Health Organization . Introduction of Haemophilus influenzae type b vaccine into immunization programmes. Geneva, Switzerland: WHO; 2000;
  17. Peltola H, Salo E, Saxen H. Incidence of Haemophilus influenzae type b meningitis during 18 years of vaccine use: observational study using routine hospital data. BMJ. 2005;330:18–19
  18. Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Njie A, Usen S, et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunization with a Hib conjugate vaccine: a prospective study. Lancet. 2005;366:144–159
  19. Achtman M. Molecular epidemiology of epidemic bacterial meningitis. Rev Med Microbiol. 1990;1:29–38
  20. Baraff LJ, Lee S, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J. 1993;12:389–394
  21. Cripps AW, Leach AJ, Lehmann D. Pneumococcal vaccination in developing countries. Lancet. 2006;368:644
  22. Peltola H. Main etiology of childhood bacterial meningitis in Latin America and the Caribbean. Pediatr Infect Dis J. 1997;16:780–787
  23. Singhi P, Bansal A, Singhi G, Singhi S. Predictor of long term neurological outcome in bacterial meningitis. Indian J Pediatr. 2007;74:369–374
  24. Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 1993;269:221–226
  25. Santos JI. Nuevo esquema de vacunación en México. Salud Pub Mex. 1999;41:1–2
  26. Pan American Health Organization . Mexico introduces pentavalent vaccine. EPI News. 1999;21:8
  27. Santos JI, Martin A, De Leon T, Rivera L, Gaitán ME, Del Rio C, et al. DTPw–HB and Hib primary and booster vaccination: combined versus separate administration to Latin American children. Vaccine. 2002;20(13–14):1887–1893
  28. de León PG, Díaz García FJ, Arredondo JL, Segura J, Cerezo SG, Santos JI. Anticapsular polysaccharide IgG concentrations in Mexican children formerly immunized with Haemophilus influenzae b PRP-T vaccine. Hum Vaccin. 2007;3:187–191
  29. Whitney C, Farley M, Hadler J, Harrison L, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein–polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737–1746
  30. Tzeng YL, Stephens DS. Epidemiology and pathogenesis of Neisseria meningitidis. Microbes Infect. 2000;2:687–700
  31. Franco-Paredes C, Rouphael N, del Rio C, Santos-Preciado JI. Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates. Int J Infect Dis. 2006;10:93–102

PII: S1201-9712(07)00200-7

doi: 10.1016/j.ijid.2007.09.012

International Journal of Infectious Diseases
Volume 12, Issue 4 , Pages 380-386 , July 2008

Article Tools